Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hodgkin Disease 2Unspecified Childhood Solid Tumor, Protocol Specific 1Sezary Syndrome 1Recurrence 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hematologic Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 6fludarabine 5Exercise 4Blood Specimen Collection 4Surveys and Questionnaires 3Immunotherapy, Adoptive 3thymoglobulin 2pegylated granulocyte colony-stimulating factor 2Voriconazole 2Stem Cell Transplantation 2Saline Solution 2Physical Therapy Modalities 2Parenteral Nutrition 2Mycophenolic Acid 2Etoposide 2Cytarabine 2CF regimen 2BNT162 Vaccine 2Azacitidine 2venetoclax 1trihexyltetradecylphosphonium chloride 1treosulfan 1shengxuening 1ruxolitinib 1ramosetron 1monalizumab 1glucarpidase 1fludarabine phosphate 1ferrous succinate 1eltrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hematologic Neoplasms × Cord Blood Stem Cell Transplantation × Clear all
NCT00959231 2013-08-26

Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease

National Cancer Institute (NCI)

Phase 2 Unknown
60 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡